Bausch + Lomb Corporation (BLCO) DCF Valuation

BAUSCH + LOMB CORPORATION (BLCO) DCF -Bewertung

CA | Healthcare | Medical - Instruments & Supplies | NYSE
Bausch + Lomb Corporation (BLCO) DCF Valuation

Fully Editable: Tailor To Your Needs In Excel Or Sheets

Professional Design: Trusted, Industry-Standard Templates

Investor-Approved Valuation Models

MAC/PC Compatible, Fully Unlocked

No Expertise Is Needed; Easy To Follow

Bausch + Lomb Corporation (BLCO) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Möchten Sie den inneren Wert der Bausch + Lomb Corporation bewerten? Unser (BLCO) DCF-Taschenrechner integriert reale Daten mit umfangreichen Anpassungsfunktionen, sodass Sie Prognosen anpassen und Ihre Anlagestrategien verbessern können.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020
AY2
2021
AY3
2022
AY4
2023
AY5
2024
FY1
2025
FY2
2026
FY3
2027
FY4
2028
FY5
2029
Revenue 3,412.0 3,765.0 3,768.0 4,146.0 4,774.0 5,198.9 5,661.7 6,165.7 6,714.5 7,312.1
Revenue Growth, % 0 10.35 0.07968127 10.03 15.15 8.9 8.9 8.9 8.9 8.9
EBITDA 739.0 762.0 599.0 512.0 614.0 863.1 939.9 1,023.6 1,114.7 1,213.9
EBITDA, % 21.66 20.24 15.9 12.35 12.86 16.6 16.6 16.6 16.6 16.6
Depreciation 442.0 415.0 379.0 382.0 436.0 544.7 593.1 645.9 703.4 766.0
Depreciation, % 12.95 11.02 10.06 9.21 9.13 10.48 10.48 10.48 10.48 10.48
EBIT 297.0 347.0 220.0 130.0 178.0 318.4 346.8 377.6 411.2 447.9
EBIT, % 8.7 9.22 5.84 3.14 3.73 6.12 6.12 6.12 6.12 6.12
Total Cash 238.0 174.0 354.0 331.0 305.0 367.7 400.4 436.1 474.9 517.2
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 645.0 721.0 724.0 839.0 1,026.0
Account Receivables, % 18.9 19.15 19.21 20.24 21.49
Inventories 616.0 572.0 628.0 1,028.0 1,036.0 1,002.4 1,091.7 1,188.9 1,294.7 1,409.9
Inventories, % 18.05 15.19 16.67 24.79 21.7 19.28 19.28 19.28 19.28 19.28
Accounts Payable 178.0 239.0 370.0 522.0 389.0 438.0 477.0 519.4 565.7 616.0
Accounts Payable, % 5.22 6.35 9.82 12.59 8.15 8.42 8.42 8.42 8.42 8.42
Capital Expenditure -259.0 -209.0 -175.0 -181.0 -291.0 -293.7 -319.9 -348.3 -379.3 -413.1
Capital Expenditure, % -7.59 -5.55 -4.64 -4.37 -6.1 -5.65 -5.65 -5.65 -5.65 -5.65
Tax Rate, % -35.47 -35.47 -35.47 -35.47 -35.47 -35.47 -35.47 -35.47 -35.47 -35.47
EBITAT -17.4 198.6 45.2 203.6 241.1 176.9 192.6 209.8 228.5 248.8
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -917.4 433.6 321.2 41.6 58.1 507.0 324.1 352.9 384.3 418.5
WACC, % 3.52 5.84 4.35 7.58 7.58 5.78 5.78 5.78 5.78 5.78
PV UFCF
SUM PV UFCF 1,690.2
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 427
Terminal Value 11,304
Present Terminal Value 8,536
Enterprise Value 10,226
Net Debt 4,479
Equity Value 5,747
Diluted Shares Outstanding, MM 352
Equity Value Per Share 16.34

What You Will Receive

  • Pre-Filled Financial Model: Utilizing Bausch + Lomb's actual data for accurate DCF valuation.
  • Comprehensive Forecast Control: Modify revenue growth, profit margins, WACC, and other essential factors.
  • Instantaneous Calculations: Automatic updates provide immediate visibility of results as adjustments are made.
  • Investor-Ready Template: A polished Excel file crafted for professional-level valuation.
  • Customizable and Reusable: Designed for adaptability, allowing repeated application for in-depth forecasts.

Key Features

  • Accurate Bausch + Lomb Financials: Gain access to reliable pre-loaded historical data and future forecasts.
  • Tailored Forecast Inputs: Modify the highlighted cells for parameters such as WACC, growth rates, and profit margins.
  • Interactive Calculations: Enjoy automatic updates for DCF, Net Present Value (NPV), and cash flow analyses.
  • Visual Reporting Dashboard: Intuitive charts and summary visuals to present your valuation outcomes effectively.
  • Designed for All Skill Levels: A user-friendly layout created for investors, CFOs, and consultants alike.

How It Works

  • Step 1: Download the prebuilt Excel template featuring Bausch + Lomb Corporation’s (BLCO) data.
  • Step 2: Review the pre-filled sheets to familiarize yourself with the key metrics.
  • Step 3: Modify the forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly access recalculated outputs, including the intrinsic value of Bausch + Lomb Corporation (BLCO).
  • Step 5: Make informed investment choices or produce reports based on the results.

Why Choose the Bausch + Lomb Calculator?

  • Designed for Experts: A sophisticated tool utilized by financial analysts, CFOs, and consultants.
  • Accurate Financials: Bausch + Lomb's historical and projected data preloaded for precision.
  • Flexible Scenario Analysis: Effortlessly explore various forecasts and assumptions.
  • Transparent Results: Automatically computes intrinsic value, NPV, and essential metrics.
  • User-Friendly: Step-by-step guidance takes you through each stage of the process.

Who Can Benefit from This Product?

  • Investors: Assess the valuation of Bausch + Lomb Corporation (BLCO) prior to making investment decisions.
  • CFOs and Financial Analysts: Improve valuation methodologies and evaluate financial forecasts.
  • Startup Founders: Understand the valuation strategies of established public companies like Bausch + Lomb Corporation (BLCO).
  • Consultants: Provide comprehensive valuation reports for your clients.
  • Students and Educators: Utilize current market data to practice and teach valuation concepts.

Contents of the Template

  • Comprehensive DCF Model: Editable template featuring in-depth valuation calculations.
  • Real-World Data: Bausch + Lomb Corporation's (BLCO) historical and projected financials preloaded for analysis.
  • Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore different scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
  • Key Ratios: Integrated analysis of profitability, efficiency, and leverage metrics.
  • Dashboard with Visual Outputs: Charts and tables provide clear and actionable results.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.